ASHLEY HALL: Open Payments
NPI 1609657287 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 82 payments from 17 companies in 2025. Trend: 2023 $19 · 2024 $2,623 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $443 |
| AstraZeneca Pharmaceuticals LP | 9 | $308 |
| Lilly USA, LLC | 11 | $139 |
| Novo Nordisk Inc | 9 | $137 |
| LEO Pharma Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $115 |
| Amgen Inc. | 5 | $89 |
| Exact Sciences Corporation | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
Products named: QULIPTA, AIRSUPRA, MOUNJARO, VRAYLAR, ANZUPGO, VOQUEZNA, XIFAXAN, BREZTRI.
Industry payments across NY — which companies pay providers there.
